Area of research
Pharmacology · Biological Psychiatry
Research interest
Research interests include Treatment of Major Depression, Tryptophan and brain disorders, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, and Mental Health Treatment and Access.
Heated yoga thaws depression: A dose-response analysis from a randomized controlled trial.
Ketamine-Assisted Psychotherapy for Treatment of an Asian American Patient with Post-Traumatic Stress Disorder (PTSD): A Case Study
Moderating effects of stigma-related barriers on ethnic identity dimensions and mental health service utilization among Black adults in the US
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators
Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial
A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.
Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients.
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation
Quantifying and addressing the impact of measurement error in network models
Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder
Four-Week Mentalizing Imagery Therapy for Family Dementia Caregivers: A Randomized Controlled Trial with Neural Circuit Changes
How family dementia caregivers perceive benefits of a 4-week mentalizing imagery therapy program: A pilot study.
Depressed Chinese Americans present predominantly psychological symptoms: A new trend or different outcomes due to methodological differences?
Diet and depression: exploring the biological mechanisms of action
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Tachyphylaxis in major depressive disorder: A review of the current state of research
Prospective association between major depressive disorder and leukocyte telomere length over two years
Circulating microRNAs as biomarkers for depression: Many candidates, few finalists
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)
Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
A Double-Blind Placebo-Controlled Trial of Maca Root as Treatment for Antidepressant-Induced Sexual Dysfunction in Women
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)